日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Implantable cardioverter-defibrillator FDA safety advisories: Impact on patient mortality and morbidity

植入式心脏复律除颤器FDA安全建议:对患者死亡率和发病率的影响

Sengupta, Jay; Kendig, Arthur C; Goormastic, Marlene; Hwang, Eui-Seock; Ching, Elizabeth A; Chung, Roy; Lindsay, Bruce D; Tchou, Patrick J; Wilkoff, Bruce L; Niebauer, Mark J; Martin, David O; Varma, Niraj; Wazni, Oussama; Saliba, Walid; Kanj, Mohamed; Bhargava, Mandeep; Dresing, Thomas; Taigen, Tyler; Ingelmo, Christopher; Bassiouny, Mohamed; Cronin, Edmond M; Wilsmore, Bradley; Rickard, John; Chung, Mina K

Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.

载脂蛋白 AI 是髓过氧化物酶催化氧化和心血管疾病患者功能障碍的选择性靶点

Zheng Lemin, Nukuna Benedicta, Brennan Marie-Luise, Sun Mingjiang, Goormastic Marlene, Settle Megan, Schmitt Dave, Fu Xiaoming, Thomson Leonor, Fox Paul L, Ischiropoulos Harry, Smith Jonathan D, Kinter Michael, Hazen Stanley L

Reoperation for coronary atherosclerosis. Changing practice in 2509 consecutive patients

冠状动脉粥样硬化再手术:2509例连续患者的治疗实践变革

Loop, F D; Lytle, B W; Cosgrove, D M; Woods, E L; Stewart, R W; Golding, L A; Goormastic, M; Taylor, P C